Loading...
Loading...
ACST| Name | Value |
|---|---|
| Revenues | -0.0M |
| Cost of Revenue | 14.1M |
| Gross Profit | -14.1M |
| Operating Expense | 4.2M |
| Operating I/L | 29.7M |
| Other Income/Expense | -67.7M |
| Interest Income | 0.2M |
| Pretax | -38.0M |
| Income Tax Expense | -8.9M |
| Net Income/Loss | -29.1M |
Acasti Pharma Inc. is a biopharmaceutical company specializing in the development and commercialization of pharmaceutical products for cardiovascular diseases. The company's primary focus is on the clinical development of CaPre, a potential treatment for cardiovascular conditions. Acasti Pharma Inc. generates revenue through strategic partnerships and the eventual commercialization of its pharmaceutical products.
